H2020HORIZONFP7
Luxembourg Institute of Health
- Country
- LULuxembourg
- Defence projects
- 0
- Projects, all programmes
- 48
- As coordinator
- 14
- EU contribution (CORDIS)
- EUR 16,455,707
- Active
- 2008 to 2026
Projects
48 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| EPNDEuropean platform for neurodegenerative disorders | H2020 | 2021 | Participant | EUR 71,500 |
| EVILReprogramming of the leukemic microenvironment by small extracellular vesicles: from characterization to therapeutic application | H2020 | 2021 | Coordinator | EUR 178,320 |
| MEGAKINEMegakines - novel tools for structural insight into receptor:chemokine complexes | H2020 | 2021 | Coordinator | EUR 178,320 |
| MUCO-IMMUNMUCOBIOME-MEDIATED IMMUNE PATHWAYS IN INFLAMMATORY BOWEL DISEASES | H2020 | 2021 | Coordinator | EUR 166,320 |
| ORCHESTRAConnecting European Cohorts to Increase Common and Effective Response to SARS-CoV-2 Pandemic: ORCHESTRA | H2020 | 2020 | Participant | EUR 932,101 |
| EATRIS-PlusConsolidating the capacities of EATRIS-ERIC for Personalised Medicine | H2020 | 2020 | Participant | EUR 313,292 |
| COVIRNAA diagnostic test to improve surveillance and care of COVID-19 patients | H2020 | 2020 | Coordinator | EUR 699,822 |
| MITOThe function and biomarker potential of mitochondrial microRNAs in hypertension | H2020 | 2020 | Coordinator | EUR 178,320 |
| unCoVerUnravelling Data for Rapid Evidence-Based Response to COVID-19 | H2020 | 2020 | Participant | EUR 36,650 |
| CARDIATEAMCARdiomyopathy in type 2 DIAbetes mellitus | H2020 | 2019 | Participant | EUR 588,156 |
| VALUE-DxThe value of diagnostics to combat antimicrobial resistance by optimising antibiotic use | H2020 | 2019 | Participant | EUR 2,587 |
| HIVACAREvaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection | H2020 | 2017 | Third party | Not stated |
| ClinnovaCentre of Excellence in Digital Health and Personalised Medicine | H2020 | 2017 | Participant | EUR 81,563 |
| SPIDIA4PSPIDIA for Personalized Medicine - Standardisation of generic Pre-analytical procedures for In-vitro DIAgnostics for Personalized Medicine | H2020 | 2017 | Participant | EUR 115,727 |
| PROOFPenumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial | H2020 | 2017 | Third party | Not stated |
| LITMUSLiver Investigation: Testing Marker Utility in Steatohepatitis | H2020 | 2017 | Participant | EUR 540,034 |
| PedCRINPaediatric Clinical Research Infrastructure Network | H2020 | 2017 | Third party | Not stated |
| HBM4EUEuropean Human Biomonitoring Initiative | H2020 | 2017 | Third party | Not stated |
| GLIOTRAINExploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics | H2020 | 2017 | Participant | EUR 250,560 |
| VISION DMDVISION-DMD - Phase 2 Clinical Trials of VBP15: An Innovative Steroid-like Intervention on Duchenne Muscular Dystrophy | H2020 | 2016 | Third party | Not stated |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.